UCLA Fielding School of Public Health's Dr. Gang Li co-authored research that finds chronic stress and an unhealthy diet may work together to fuel the early development of pancreatic cancer. Along with serving as a professor of biostatistics, Dr. Li also serves with UCLA's Johnson Comprehensive Cancer Center, part of the UCLA Health system.
Education
- PhD, Statistics; University of Washington, Seattle, WA
Women should start getting every-other-year mammograms at age 40 instead of waiting until 50, according to a draft recommendation from a federal task force.
The U.S. Preventive Services Task Force has long said women can choose to start breast cancer screening as young as 40, with a stronger recommendation that they get the X-ray exams every two years from age 50 through 74.
UCLA researchers have found that commonly used hormone therapies for women diagnosed with breast cancer do not appear to cause significant cognitive dysfunction following the treatment.
Breast cancer survivors who experienced trauma early in life and depression after their cancer treatments are at increased risk of persistent fatigue, a new UCLA study shows. Some of the key predictors of longer-term fatigue for this group of women include elevated levels of depressive symptoms after treatment and a history of childhood adversity, such as abuse, neglect, household conflict and disorganization.
CHINESE RESIDENTS ACCOUNT FOR 19.3% of the world’s population, yet 26.9% of all cancer-related deaths occur in China.
UCLA researcher Dr. Roshan Bastani will lead a $6.6 million research study awarded by the Patient-Centered Outcomes Research Institute (PCORI) to investigate the comparative effectiveness of strategies designed to increase receipt of the human papillomavirus (HPV) vaccine among adolescents.
A fundamental shift in how cancer research is conducted and cancer care is provided in the United States is required in order to deliver on the US Cancer Moonshot initiative, according to a major new report published today in The Lancet Oncology.
As of July 1, 2017 Dr. Patricia Ganz will assume editorial leadership of one of the oldest and most internationally respected oncology journals, JNCI: Journal of the National Cancer Institute.